XML 50 R42.htm IDEA: XBRL DOCUMENT
v3.24.3

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) | 9 Months Ended |  |
--- | --- | --- | ---
Sep. 30, 2024 Segment $ / shares shares | Jan. 05, 2024 $ / shares | Dec. 31, 2023 $ / shares
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Amortizes internal-use software costs using the straight-line method over the estimated useful life of asset | 3 years |  |
Number of reporting segments | Segment | 2 |  |
Common stock, par value (in dollars per share) | $ 0.001 |  | $ 0.001
Standard BioTools | Public Warrants |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Initial public offering warrants issued | shares | 5,519,991 |  |
Standard BioTools | Private Placement Warrants |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Initial public offering warrants issued | shares | 5,013,333 |  |
Common Stock |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Exercise price of warrants |  | $ 1.11 |
Common Stock | SomaLogic Inc. |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Common stock, par value (in dollars per share) |  | 0.0001 |
Common Stock | Public Warrants | SomaLogic Inc. |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Common stock, par value (in dollars per share) | $ 0.0001 |  |
Common Stock | Standard BioTools |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Common stock, par value (in dollars per share) |  | $ 0.001 |
Common Stock | Standard BioTools | Public Warrants |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Exercise price of warrants | 11.5 |  |
Common Stock | Standard BioTools | Private Placement Warrants |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Exercise price of warrants | $ 11.5 |  |
Product revenue | Maximum |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Terms of payment period | 60 days |  |
Product revenue | Minimum |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Terms of payment period | 30 days |  |
Service revenue | Maximum |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Performance obligation period | 4 years |  |
Service revenue | Minimum |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Performance obligation period | 1 year |  |
Capitalized Software Development Costs |  |  |
Schedule Of Significant Accounting Policies [Line Items] |  |  |
Amortization on product-by-product basis using straight-line method over periods | 3 years |  |

X
- Definition Amortization on product-by-product using straight-line method over periods. + References No definition available. + Details
Name: | lab_AmortizationOnProductByProductUsingStraightLineMethodOverPeriods
Namespace Prefix: | lab_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amortizes internal-use software costs using straight-line method + References No definition available. + Details
Name: | lab_AmortizesInternalUseSoftwareCostsUsingStraightLineMethod
Namespace Prefix: | lab_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revenue From Contract With Customer, Performance Obligation Period + References No definition available. + Details
Name: | lab_RevenueFromContractWithCustomerPerformanceObligationPeriod
Namespace Prefix: | lab_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Revenue From Contract With Customer, Terms Of Payment Period + References No definition available. + Details
Name: | lab_RevenueFromContractWithCustomerTermsOfPaymentPeriod
Namespace Prefix: | lab_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Significant Accounting Policies [Line Items] + References No definition available. + Details
Name: | lab_ScheduleOfSignificantAccountingPoliciesLineItems
Namespace Prefix: | lab_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18 + Details
Name: | us-gaap_NumberOfReportableSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=lab_StandardBiotoolsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lab_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lab_PrivatePlacementWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=lab_SomalogicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PropertyPlantAndEquipmentByTypeAxis=lab_CapitalizedSoftwareDevelopmentCostsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |